What do we need to know about the omicron var...

A recent survey found roughly three million Canadians are taking GLP-1 medications like Ozempic and Mounjaro. The drugs can reduce appetite and cravings, and could also affect the body’s fat and muscle stores. Jennifer Brown, director of program innovation at Obesity Canada and a ...  Show more

Researchers in Canada and around the world are exploring ways stem cells could help treat conditions like diabetes, Parkinson's and heart disease, but the hype sometimes outpaces the science. Neurosurgeon and researcher Dr. Sheila Singh of McMaster University and King’s College L ...  Show more

Updated versions of coronavirus vaccines targeting the Omicron variant have recently been announced by Pfizer and Moderna. There's been an impressive turnaround time and yet still the virus has continued to mutate. 

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Rec ...

Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen. 

New variants of the coronavirus are circulating around the globe and causing some concern among experts. One in particular, variant B.1.1.7, has been found to more easily spread from one person to another.  This new variant has already been identified in several states in the US. ...  Show more